5th World Congress on Cancer Therapy
Xiaoliang X. Xu
Zhongshan University, China
Xu is a principle investigator and group leader in Zhongshan Ophthalmic Center of Zhongshan University, Basic Research Co-leader and Senior Scientist at Memorial Sloan Kettering Cancer Center (MSKCC), and Assistant Professor at New York Eye and Ear Infi rmary and New York Medical College. He got MD from Zhejiang University and PhD from Shanhai Jiaotong University. His research was the key to identifying the cell of origin of retinoblastoma and to identifying a central signaling pathway for the development of this cancer; this work resulted in fi rst-author publications in Cell, Nature, and the American Journal of Pathology.